RXRX News
Recursion Pharmaceuticals, Inc.
$4.41
+$0.29(+6.92%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$2.21B
Volume
13.50M
52W Range
$2.77 - $7.18
Target Price
$6.90
RXRX news: the latest Recursion Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest RXRX News
- Analysts Offer Insights on Healthcare Companies: 4D Molecular Therapeutics (FDMT), Recursion Pharmaceuticals (RXRX) and Contineum Therapeutics, Inc. Class A (CTNM)TipRanks Newsroom · Sep 21, 2026
- Recursion’s REC-7735 Trial: Early Precision Oncology Data That Could Move RXRXTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 17, 2026
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Recursion Pharmaceuticals (RXRX), Teladoc (TDOC) and Oscar Health (OSCR)TipRanks Newsroom · Sep 15, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $4.41 | +6.9% | 13.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW